Gary Headden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gary Headden has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Alan Maisel
Division of Cardiovascular Medicine, University of California , San Diego, La Jolla, CA
1 shared publication - Brian Hiestand
Wake Forest School of Medicine
1 shared publication - Christian Mueller
University Hospital Basel, University of Basel
1 shared publication - Deborah B. Diercks
Department of Emergency Medicine UT Southwestern Medical Center Dallas Texas USA
1 shared publication - Donald Schreiber
Department of Emergency Medicine, Stanford University School of Medicine Palo Alto, CA, USA
1 shared publication - Fred S. Apple
Department of Laboratory Medicine and Pathology, Hennepin Healthcare/Hennepin County Medical Center and University of Minnesota, Minneapolis (F.S.A.).
1 shared publication
Latest Publications
- Open Access
- 30 June 2022
- Published by The Korean Society of Emergency Medicine in Clinical and Experimental Emergency Medicine
- Vol. 9 (2) , 140-145
Finding acute coronary syndrome with serial troponin testing for rapid assessment of cardiac ischemic symptoms (FAST-TRAC): a study protocol
Objective To determine the utility of a highly sensitive troponin assay when utilized in the emergency department.Methods The FAST-TRAC study prospectively enrolled >1,500 emergency department patients with suspected acute coronary syndrome within 6 hours of symptom onset and 2 hours of emergency department presentation. It has several unique features that are not found in the majority of studies evaluating troponin. These include a very early presenting population in whom prospective data collection of risk score parameters and the physician’s clinical impression of the probability of acute coronary syndrome before any troponin data were available. Furthermore, two gold standard diagnostic definitions were determined by a pair of cardiologists reviewing two separate data sets; one that included all local troponin testing results and a second that excluded troponin testing so that diagnosis was based solely on clinical grounds. By this method, a statistically valid head-to-head comparison of contemporary and high sensitivity troponin testing is obtainable. Finally, because of a significant delay in sample processing, a unique ability to define the molecular stability of various troponin assays is possible.Trial registration ClinicalTrials.gov Identifier NCT00880802
- 30 June 2022
- Published by The Korean Society of Emergency Medicine in Clinical and Experimental Emergency Medicine
- Vol. 9 (2) , 140-145
Open AccessFinding acute coronary syndrome with serial troponin testing for rapid assessment of cardiac ischemic symptoms (FAST-TRAC): a study protocol
Objective To determine the utility of a highly sensitive troponin assay when utilized in the emergency department.Methods The FAST-TRAC study prospectively enrolled >1,500 emergency department patients with suspected acute coronary syndrome within 6 hours of symptom onset and 2 hours of emergency department presentation. It has several unique features that are not found in the majority of studies evaluating troponin. These include a very early presenting population in whom prospective data collection of risk score parameters and the physician’s clinical impression of the probability of acute coronary syndrome before any troponin data were available. Furthermore, two gold standard diagnostic definitions were determined by a pair of cardiologists reviewing two separate data sets; one that included all local troponin testing results and a second that excluded troponin testing so that diagnosis was based solely on clinical grounds. By this method, a statistically valid head-to-head comparison of contemporary and high sensitivity troponin testing is obtainable. Finally, because of a significant delay in sample processing, a unique ability to define the molecular stability of various troponin assays is possible.Trial registration ClinicalTrials.gov Identifier NCT00880802